Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy von Oner, Gizem, Önder, Semen, Karatay, Hüseyin, Ak, Naziye, Tükenmez, Mustafa, Müslümanoğlu, Mahmut, İğci, Abdullah, Dincçağ, Ahmet, Özmen, Vahit, Aydiner, Adnan, Yavuz, Ekrem, Cabioğlu, Neslihan

Volltext

Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy von Cabıoğlu, Neslihan, Karanlık, Hasan, Yılmaz, Ravza, Emiroğlu, Selman, Tükenmez, Mustafa, Bademler, Süleyman, Şimşek, Duygu Has, Kantarcı, Tarık Recep, Yirgin, İnci Kızıldağ, Bayram, Aysel, Dursun, Memduh

Volltext

Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy von Oner, Gizem, Önder, Semen, Karatay, Hüseyin, Ak, Naziye, Tükenmez, Mustafa, Müslümanoğlu, Mahmut, İğci, Abdullah, Dincçağ, Ahmet, Özmen, Vahit, Aydiner, Adnan, Yavuz, Ekrem, Cabioğlu, Neslihan

Volltext

Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy von CabioÄlu, Neslihan, Karanlik, Hasan, Yilmaz, Ravza, EmiroÄlu, Selman, Tükenmez, Mustafa, Bademler, Süleyman, ÅimÅek, Duygu Has, Kantarci, Tarik Recep, Yirgin, Ä°nci KizildaÄ, Bayram, Aysel, Dursun, Memduh

Volltext

Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy von Oner, Gizem, ünder, Semen, Karatay, Hüseyin, Ak, Naziye, Tükenmez, Mustafa, MüslümanoÄlu, Mahmut, Ä°Äci, Abdullah, DincçaÄ, Ahmet, üzmen, Vahit, Aydiner, Adnan, Yavuz, Ekrem, CabioÄlu, Neslihan

Volltext